Current Assets

Securities Received As Collateral

Pfizer Securities Received As Collateral decreased by 48.2% to $29.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 94.9%, from $564.00M to $29.00M.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityVolatile
First reportedQ1 2018
Last reportedQ1 2026May 5, 2026

How to read this metric

Higher levels indicate increased activity in securities lending or repo markets, which can enhance yield but also increase counterparty exposure.

Detailed definition

This represents the fair value of securities held by the company that were received from counterparties as collateral fo...

Peer comparison

Common for large financial institutions; peers report this as part of their collateral management and liquidity disclosures.

Metric ID: current_assets_securities_received_as_collateral

Historical Data

15 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22Q1 '23Q2 '23Q3 '23Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$25.00M$236.00M$341.00M$755.00M$1.50B$530.00M$366.00M$256.00M$274.00M$288.00M$129.00M$564.00M$43.00M$56.00M$29.00M
QoQ Change+844.0%+44.5%+121.4%+98.7%-64.7%-30.9%-30.1%+7.0%+5.1%-55.2%+337.2%-92.4%+30.2%-48.2%
YoY Change>999%+535.6%+55.4%-51.5%-82.9%-48.3%-21.3%-49.6%+105.8%-85.1%-56.6%-94.9%
Range$25.00M$1.50B
CAGR+4.3%
Avg YoY Growth+260.6%
Median YoY Growth-49.0%

Frequently Asked Questions

What is Pfizer's securities received as collateral?
Pfizer (PFE) reported securities received as collateral of $29.00M in Q1 2026.
How has Pfizer's securities received as collateral changed year-over-year?
Pfizer's securities received as collateral decreased by 94.9% year-over-year, from $564.00M to $29.00M.
What does securities received as collateral mean?
The value of securities held as collateral for financial transactions.